Gland Pharma Limited reports a change in its board or management
In short
Gland Pharma Limited informed the NSE on change in directors, KMP, SMP, auditor or RTA. No figure, date, scheme name or validity period is given in the text. In simple terms, the company has told the exchange that there has been a change in its senior personnel or related service providers. No closing or deadline date is stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.